Cravath Swaine & Moore and Shearman & Sterling have taken the lead roles on Johnson & Johnson's $21.3bn (£12.8bn) acquisition of orthopaedic devices manufacturer Synthes, reports the Am Law Daily. Cravath is acting for Johnson & Johnson on the deal, which ranks as the healthcare giant's largest to date. The US firm's team is led by corporate partner Robert Townsend, alongside corporate partner Damien Zoubek, compensation and benefits partner Eric Hilfers and tax partner Andrew Needham.
April 28, 2011 at 05:32 AM
1 minute read
The original version of this story was published on Legalweek
Cravath Swaine & Moore and Shearman & Sterling have taken the lead roles on Johnson & Johnson’s $21.3bn (£12.8bn) acquisition of orthopaedic devices manufacturer Synthes, reports the Am Law Daily.
Cravath is acting for Johnson & Johnson on the deal, which ranks as the healthcare giant’s largest to date. The US firm’s team is led by corporate partner Robert Townsend, alongside corporate partner Damien Zoubek, compensation and benefits partner Eric Hilfers and tax partner Andrew Needham.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
